Haemonetics CorporationHAENYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P38
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -15.95% |
| Q3 2025 | 539.96% |
| Q2 2025 | -85.08% |
| Q1 2025 | 166.32% |
| Q4 2024 | -10.36% |
| Q3 2024 | 278.05% |
| Q2 2024 | -142.79% |
| Q1 2024 | 11966.85% |
| Q4 2023 | -100.54% |
| Q3 2023 | 419.35% |
| Q3 2023 | -76.03% |
| Q1 2023 | 23.59% |
| Q4 2022 | -25.99% |
| Q4 2022 | 107.27% |
| Q3 2022 | -38.29% |
| Q1 2022 | 9.00% |
| Q1 2022 | 43.66% |
| Q4 2021 | 2686.90% |
| Q3 2021 | -208.60% |
| Q1 2021 | -97.67% |
| Q4 2020 | 127.37% |
| Q3 2020 | 146.83% |
| Q2 2020 | -74.55% |
| Q1 2020 | -41.47% |
| Q4 2019 | 165.15% |
| Q3 2019 | 1037.79% |
| Q2 2019 | -87.27% |
| Q1 2019 | -64.52% |
| Q4 2018 | 1.41% |
| Q3 2018 | 148.06% |
| Q2 2018 | -59.88% |
| Q1 2018 | -11.88% |
| Q4 2017 | 11.02% |
| Q3 2017 | 53.29% |
| Q3 2017 | 11.13% |
| Q1 2017 | -37.36% |
| Q4 2016 | 40.59% |
| Q4 2016 | 27.92% |
| Q3 2016 | -42.36% |
| Q1 2016 | 67.19% |